Latest Breaking News On - Nan fung group life sciences - Page 1 : comparemela.com

The fresh round was jointly led by AdvanTech Capital and Vivo Capital, a Palo Alto-based investment firm that backs the US and China healthcare market. 

San diegoUnited statesHong kongHongbo luAlex qiaoAblaze pharmaceuticalsNan fung group life sciencesAdvantech capitalVivo capitalPalo alto basedNan fung groupNan fung life sciencesPivotal bioventure partners chinaBio partnersSamsara biocapitalVenrock healthcare capital